Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia

Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Emmaline Zantua, Yu, Jeryl Ritzi Tan, Santos, Salvador Miclat Abad, Jamora, Roland Dominic Go
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840242/
https://www.ncbi.nlm.nih.gov/pubmed/33278866
http://dx.doi.org/10.14802/jmd.20091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840242/
https://www.ncbi.nlm.nih.gov/pubmed/33278866
http://dx.doi.org/10.14802/jmd.20091

Ejemplares similares